Area of research
Surgery · Biomedical Engineering
Research interest
Research interests include Mechanical Circulatory Support Devices, Cardiac Structural Anomalies and Repair, Transplantation: Methods and Outcomes, and Renal Transplantation Outcomes and Treatments.
Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection: An Analysis of the Surveillance HeartCare Outcomes Registry.
Cell-Free DNA Profiles End-Organ Injury and Predicts Outcomes in Advanced Heart Failure With Left Ventricular Assist Device Implantation.
Multimodal molecular testing provides prognostic value for heart transplant recipients.
Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAs.
Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy.
Evaluation of Women With Peripartum or Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study.
Care Models for the Genetic Evaluation of Dilated Cardiomyopathy at Sites of the DCM Consortium
Integrative Clinical–Molecular Modeling Identifies
<i>LRRN4CL</i>
as a Determinant of Structural and Functional Myocardial Improvement
Guideline-Directed Medical Therapy for Patients With a Left Ventricular Assist Device
Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators.
Summary of the International Society for Heart and Lung Transplantation consensus conference on emerging understanding of antibodies and antibody-mediated rejection in heart transplantation
Contemporary Antibody-Mediated Rejection in Heart Transplantation
Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes
Two-year outcomes in the direct oral anticoagulant apixaban in left ventricular assist devices (DOAC LVAD) study
Contemporary Antibody-Mediated Rejection in Heart Transplantation: JACC: Heart Failure Position Statement.
Implementing Precision Medicine for Dilated Cardiomyopathy: Insights From the DCM Consortium
Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine Study.
The Authors’ Perspective on 'Summary of the International Society for Heart and Lung Transplantation Consensus Conference on Emerging Understanding of Antibodies and Antibody-mediated Rejection in Heart Transplantation'
Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study.
Utility of Plasma Cell-free Chromatin Immunoprecipitation to Detect Cardiac Allograft Rejection
Sex Differences in Circulating microRNAs After Heart Transplantation on Behalf of the GRAfT Investigators
Cell-Free DNA Profiles End-Organ Injury and Predicts Outcomes in Advanced Heart Failure With Left Ventricular Assist Device Implantation
Evaluation of Women with Peripartum or Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study
Implementing Precision Medicine for Dilated Cardiomyopathy: Insights From the DCM Consortium.
Dosing of apixaban with left ventricular assist devices: A need for greater clarity
Donor-Derived Cell-Free DNA Stratifies Risk of Mortality and Graft Dysfunction in Severe Acute Cardiac Allograft Rejection
CD163 <sup>+</sup> Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma
The International Society for Heart and Lung Transplantation (ISHLT): 2024 infection definitions for durable and acute mechanical circulatory support devices